Hitoshi Kamiya

TL;DR: The skin test was applied clinically in an institution for mentally retarded children immediately after varicella infection occurred in a patient, and seems clinically useful in the determination of susceptibility of individuals to clinicalvaricella.

TL;DR: A live varicella vaccine was used in 11 susceptible children in remission from acute leukemia, ten of whom had been in remission for six months or less, and in 6 children with neuroblastoma and retinoblastoma.

TL;DR: Replication of varicella-zoster virus (VZV) and expression of VZV nuclear antigen are inhibited in human embryonic lung fibroblast (HEL) cells pretreated with recombinant tumor necrosis factor (TNF) alpha for 24 h.

TL;DR: An improved varicella-zoster virus (VZV) skin test antigen was used to assess cell-mediated immunity to VZV and resulted in 8 of 12 elderly subjects (greater than 60 years old) and 4 of 6 patients with collagen vascular diseases, who were V zoster-skin test negative but purified protein derivative tuberculin test-positive, became V ZV skin test- positive.

TL;DR: The burden of severe rotavirus disease among Japanese children aged <5 years is substantial and warrants consideration of vaccination as a prevention strategy.